Skip to main content

Gram-negative Bacteremia clinical trials at UCSF

1 research study open to eligible people

Showing trials for
  • Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial

    open to eligible people ages 18 years and up

    The Gram-negative bloodstream infection Oral Antibiotic Therapy trial (The GOAT Trial) is a multi-center, randomized clinical trial that hypothesizes that early transition to oral antibiotic therapy for the treatment of Gram-Negative BloodStream Infection (GN-BSI) is as effective but safer than remaining on intravenous (IV) antibiotic therapy for the duration of treatment.

    San Francisco, California and other locations

Our lead scientists for Gram-negative Bacteremia research studies include .

Last updated: